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PROTOCOL

Open Access

Predicting OptimaL cAncer RehabIlitation and
Supportive care (POLARIS): rationale and design
for meta-analyses of individual patient data of
randomized controlled trials that evaluate the
effect of physical activity and psychosocial
interventions on health-related quality of life in
cancer survivors
Laurien M Buffart1*, Joeri Kalter1, Mai JM Chinapaw2, Martijn W Heymans1, Neil K Aaronson3, Kerry S Courneya4,
Paul B Jacobsen5, Robert U Newton6, Irma M Verdonck-de Leeuw7,8 and Johannes Brug1

Abstract
Background: Effective interventions to improve quality of life of cancer survivors are essential. Numerous
randomized controlled trials have evaluated the effects of physical activity or psychosocial interventions on
health-related quality of life of cancer survivors, with generally small sample sizes and modest effects. Better
targeted interventions may result in larger effects. To realize such targeted interventions, we must determine
which interventions that are presently available work for which patients, and what the underlying mechanisms
are (that is, the moderators and mediators of physical activity and psychosocial interventions). Individual patient
data meta-analysis has been described as the ‘gold standard’ of systematic review methodology. Instead of
extracting aggregate data from study reports or from authors, the original research data are sought directly
from the investigators. Individual patient data meta-analyses allow for adequate statistical analysis of
intervention effects and moderators of such effects.
Here, we report the rationale and design of the Predicting OptimaL cAncer RehabIlitation and Supportive care
(POLARIS) Consortium. The primary aim of POLARIS is 1) to conduct meta-analyses based on individual patient
data to evaluate the effect of physical activity and psychosocial interventions on the health-related quality of life
of cancer survivors; 2) to identify important demographic, clinical, personal, or intervention-related moderators of
the effect; and 3) to build and validate clinical prediction models identifying the most relevant predictors of
intervention success.
(Continued on next page)
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Methods/Design: We will invite investigators of randomized controlled trials that evaluate the effects of
physical activity and/or psychosocial interventions on health-related quality of life compared with a wait-list,
usual care or attention control group among adult cancer survivors to join the POLARIS consortium and share
their data for use in pooled analyses that will address the proposed aims. We are in the process of identifying
eligible randomized controlled trials through literature searches in four databases. To date, we have identified
132 eligible and unique trials.
Discussion: The POLARIS consortium will conduct the first individual patient data meta-analyses in order to
generate evidence essential to targeting physical activity and psychosocial programs to the individual survivor’s
characteristics, capabilities, and preferences.
Registration: PROSPERO: International prospective register of systematic reviews, CRD42013003805
Keywords: Physical activity, Exercise, Neoplasms, Psychotherapy, Health-related quality of life, Rehabilitation,
Individual patient data meta-analysis

Background
Worldwide, it has been estimated that there were about
12.7 million cancer cases and 7.6 million cancer deaths
in 2008 [1]. Due to advances in early detection and
treatment, survival after cancer diagnosis has improved
substantially. Nevertheless, for most patients, cancer
survivorship (that is, from the time of diagnosis [2]) is
associated with significant adverse physical and psychosocial problems. These include fatigue, pain, increased
risk of anxiety and depression, reduced physical fitness
and physical function [3,4], and impaired health-related
quality of life (HRQoL) [5,6]. The term HRQoL denotes
a range of health outcomes and effects, including physical,
mental and social functioning, symptom burden and
perceived health status [7,8].
A range of physical activity and psychosocial interventions targeting HRQoL outcomes in cancer survivors have
been developed and evaluated. Many of these interventions have been studied in the context of a randomized
controlled trial (RCT). In general, meta-analyses of these
RCTs have yielded significant, positive results, although
the mean effect sizes tend to be small to moderate [9-12].
One possible explanation for the lack of larger effect
sizes is that these interventions are typically offered to
a heterogeneous group of cancer survivors and are not
sufficiently targeted to specific patients. Also, the use of
different HRQoL definitions and assessment tools undoubtedly contributes to the relatively wide range of findings
regarding the strength of intervention effects. Finally,
determinants of HRQoL may vary between individuals
and change over time. Thus, similar to developments in
personalized primary cancer therapy, physical activity
and psychosocial interventions should be optimally
targeted to the individual’s characteristics, health state,
needs, preferences, capabilities and opportunities.
To be able to shift from a ‘one-size-fits-all’ approach
to more personalized physical activity and psychosocial

interventions, it is essential to know which existing programs work, for whom, and under what circumstances
(that is, to identify important moderators of intervention
effects). Moderators identify which (subgroups of) patients
are most responsive to the intervention, and which are
not responsive, providing valuable information for decision-making [13]. The few published studies of potential
moderators of the effects of physical activity and psychosocial interventions have suggested that demographic,
clinical and personal factors such as age, marital status,
disease stage, type of treatment, and baseline functioning
may help to understand differences in responses to
physical activity and psychosocial interventions [14-18].
However, most of these earlier reports were based on
single studies that were not designed or powered to
analyze moderating effects and conduct subsequent
stratified analyses.
To further improve the effectiveness and efficiency of
physical activity and psychosocial interventions, it is also
important to identify and subsequently target critical intervention components (that is, mediators of intervention
effect). Mediators are causal links between the intervention and the outcome and identify how an intervention
might achieve its effects. For example, previous studies
have shown that fatigue and psychological distress may
mediate the association between physical activity and
HRQoL [19,20]. However, such studies are scarce.
An individual patient data (IPD) meta-analysis has been
suggested as the preferred method to identify moderators
of intervention effects [21]. In contrast to meta-regression
analyses of aggregated data used in study-level metaanalyses, an IPD meta-analysis allows for testing of interactions to evaluate whether patient and setting characteristics
are related significantly to treatment effects [21]. Other key
benefits of an IPD meta-analysis include the larger number
of data points, facilitating more powerful statistical
conclusions based on careful evaluation of modeling
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assumptions and accounting for missing data at the individual patient level, the ability to standardize analytical
techniques, inclusion criteria and outcome definitions
across studies, the possibility of identifying relevant
subgroups, and the ability to develop and test new and
existing prediction models [22-24].
In this paper, we describe the protocol of the Predicting
OptimaL cAncer RehabIlitation and Supportive care
(POLARIS) project. The primary objectives of the POLARIS
project are (1) to conduct IPD meta-analyses to evaluate
the effects of physical activity and psychosocial interventions on the HRQoL of cancer survivors; (2) to identify
those demographic, clinical and personal characteristics,
and intervention types and circumstances that moderate
the effects of physical activity and psychosocial interventions; and (3) to build and validate clinical prediction
models that identify the most relevant predictors of intervention success (that is, improvement in HRQoL). The
secondary aim of the project is to explore which variables
mediate the effect of physical activity and psychosocial
interventions on HRQoL.
To our knowledge, this is the first IPD meta-analysis
conducted on the effects of physical activity and psychosocial interventions on HRQoL of cancer survivors. For
the POLARIS project, we have established a consortium
that will be expanded to include as many investigators
as possible who have conducted RCTs evaluating the effects of physical activity and/or psychosocial interventions
on HRQoL.

Methods/Design
Inclusion and exclusion criteria

For POLARIS, we will include RCTs conducted among
adult cancer survivors where the effects of physical activity
and/or psychosocial interventions on HRQoL are evaluated in comparison to a wait-list, usual care or attention
control group (Table 1). In addition, the RCTs should have
approval of a Medical Ethics Committee as well as signed
informed consent of each participant. Psychosocial inter-
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ventions will be included if they fit into the first four categories of the framework proposed by Cunningham [25].
This framework classifies psychosocial interventions into
five categories: 1) patient education; 2) social support; 3)
coping skills training; 4) psychotherapy; and 5) spiritual/
existential therapy. Although we acknowledge the importance, we will initially exclude studies focusing on spiritual
or existential therapy, including meditation and mindfulness, in order to reduce the heterogeneity among the
interventions to be included. We also excluded studies
focusing on yoga, pain management, diet or multimodal
lifestyle interventions (for example, physical activity and
diet combined).
Identification and selection of studies

We used several strategies to identify eligible studies, including literature searches and personal communication
with experts in the field, collaborators and colleagues.
Electronic databases of PubMed, EMBASE, PsycINFO,
and CINAHL were searched, without language restrictions, to obtain an overview of studies published. Because
of language barriers, for the time being we have only
included articles published in English, German or Dutch.
We used medical subject heading (MESH) and text words
related to cancer, physical activity, exercise (that is, form
of physical activity that is planned - structured and repetitive - and aims to improve fitness, performance or health
[26]), psychosocial therapy, (health-related) quality of
life, randomized controlled trials and adult. Detailed
search strategies of all databases are available on request
[See Additional file 1 for the strategy in PubMed]. We
identified additional records by examining other sources
(that is, systematic reviews, meta-analyses, personal communication with experts in the field, collaborators and
colleagues) until no further studies were found.
To date, based on the search through September 2012,
we have identified a total of 1,779 records through database searching, and an additional 41 records through
other sources (Figure 1). After removing duplicates, we

Table 1 Study inclusion criteria
1.

Study design

Randomized controlled trial

2.

Patients

Adult (≥ 18 years) cancer survivors

3.

Intervention

Physical activity or psychosocial intervention
Physical activity intervention

Psychosocial intervention1

Physical activity advise or education

Providing information/counseling

Aerobic exercise

Support groups

Resistance exercise

Coping skills training

Combination

Psychotherapy

4.

Control group

Wait-list, usual care or attention control

5.

Outcome

Health-related quality of life included as primary or secondary outcome measure

1

According to the Framework proposed by Cunningham [25].
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Figure 1 Flow chart of study selection.

screened 1,423 records on title and abstract, of which
957 were out of scope. We assessed full text articles of
466 records for eligibility, of which 208 met the inclusion criteria. We excluded 76 of these articles because
they were descriptions of a study protocol, or were
multiple publications from the same trial. Finally, 132
unique RCTs met our inclusion criteria (Table 1). We
will invite the principal investigators of all 132 studies
to participate in the POLARIS consortium. This will

involve sharing their trial data and participating in analyses and manuscript preparation (see below).
Core data set and variables

The main outcome measures are overall HRQoL and
specific HRQoL domains (for example, physical, psychological, functional, and social well-being) measured such
multidimensional questionnaires as the European Organization for Research and Treatment of Cancer Quality of
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Life Questionnaire - Core 30 (EORTC QLQ-C30) [27], the
Short Form-36 Item Health Survey(SF-36) [28] and its
abbreviated version, the SF-12 [29], the Functional Assessment of Chronic Illness Therapy (FACIT) [30], the
Functional Assessment of Cancer Therapy (FACT) [31],
and the EuroQol 5D (EQ5D) [32]. Other patient-related
outcomes of interest and baseline characteristics include
physical activity (measured by self-report and/or objective
assessment instruments) and physical fitness (for example,
peak oxygen uptake (VO2)), body composition, symptoms
(for example, fatigue) and psychosocial variables including
anxiety, depression, distress, mood, self-esteem, sleep quality and social support (Table 2). No outcome measure will
be excluded a priori.
Relevant baseline characteristics to be included in the
POLARIS database include the patient and center identifier, important demographic and clinical variables, as
well as intervention characteristics (Table 2).
Establishing the collaborative group

The POLARIS Steering Committee will send a letter of invitation to join the POLARIS consortium to the principal
investigator of each study that is eligible for the POLARIS
database. This invitation contains a short introduction to
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POLARIS, including the aim and inclusion criteria, and a
short description of the POLARIS policy and procedures.
Reminders will be sent to principal investigators who
do not respond to the first letter of invitation, and telephone contact will be sought. If necessary, another
(principle) investigator involved in the project will be
contacted. If, and when, the principal investigators express interest in joining the consortium and sharing
their data, they will be asked to provide more trial information and to describe which data they are willing
to share with the POLARIS database. Further, the full
POLARIS policy and a data sharing agreement form
will be sent to the principal investigator. Reasons for
refusal will be recorded. After receiving the signed data
sharing agreement form, a data transfer protocol will
be sent with a suggested data-coding scheme allowing
flexibility in the format to ensure convenience to all
collaborators. Alternatively, if data management support
is needed, the dataset may be transferred with the original
coding scheme.
Data acquisition, collection and checking

We will ask study collaborators to supply raw data as
outlined by the data request form. The data can be

Table 2 Overview primary, secondary outcome and independent variables
Primary outcome measures

Assessment instrument

Health-related quality of life

For example, EORTC QLQ C30, FACIT, FACT, SF-36, SF-12, EQ5D.

Secondary outcome measures and
independent variables

Variable name

Psychosocial factors

Fatigue, depression, anxiety, mood state, stress/distress, self-esteem, anger, sleep quality, social support.

Physical activity and fitness

Functional performance (for example, 6 min walk test), muscle strength, aerobic fitness (for example,
peak VO2), physical activity (objectively or by self-report).

Body composition

Height, weight, body mass index, fat mass, lean body mass, thickness of skin folds, body fat (in
percentages), arm circumference, waist circumference, hip circumference, waist-hip ratio, bone mineral
density.

Baseline characteristics

Patient identifier, center identifier, date of diagnosis, time since diagnosis, date of randomization, and
timing of intervention (pre/during/post intervention or mixed timing).

Demographic variables

Age, gender, family income, employment status, level of education, marital status, ethnicity/race,
smoking, alcohol use, menopausal status, performance status (for example, Karnofsky Performance
Scale).

Clinical characteristics

Cancer diagnosis (for example, breast cancer), cancer staging and grading, TNM Classification of
Malignant Tumors, oncologic history, recurrence of cancer, co-morbidities, treatment of co-morbidities,
cancer-related pain, medication use, type of medication, type of treatment (for example, chemo/radio/
hormone therapy), number of cycles, time since treatment, currently under treatment, complications
during treatment, other treatments used (for example, immunotherapy, stem cell transplantation).

Psychosocial intervention characteristics

Method of delivery (for example, telephone support, face-to-face), intervention type (for example,
education, cognitive behavioral therapy, psychotherapeutic), intervention format (for example, group,
individual, couples, web-based), total number of sessions of the intervention, number of care providers
involved in the intervention, profession of care providers involved in the intervention, training given to
the care providers involved in the intervention, compliance.

Physical activity intervention characteristics

Intervention duration, exercise mode (for example, resistance, endurance), exercise intensity, exercise
frequency, exercise session duration, exercise supervision, compliance.

EORTC QLQ C30, European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30; EQ5D, EuroQoL 5D; FACIT, Functional
Assessment of Chronic Illness Therapy; FACT, Functional Assessment of Cancer Therapy; peak VO2, peak oxygen consumption; SF-36, Short Form-36; SF-12, Short
Form-12; TNM, tumor node metastasis.
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transferred in any electronic format (for example, SPSS,
SAS, and STATA). Data will be transferred using a
password-protected encryption (for example, AxCrypt).
Once the original data file is received from the principal
investigator, it will be transferred to SPSS (IBM SPSS Statistics for Windows, Version 20.0. Armonk, NY, USA) and
the original data will be archived for backup purposes.
Before transferring the data to the POLARIS database,
the data sets must be anonymized by the original investigators (that is, have all directly identifiable material,
including name, address, postal code or medical record
number removed). A unique patient identification number
should be provided to facilitate communication and data
queries.
We will examine the original data for completeness
and consistency using the following protocol: summary
statistics for all variables will be sent back to collaborators to verify categories, units of measurements, and
comparing baseline characteristics with previous publications. In addition, we will verify consistency of data
within individuals, highlight potential outliers and identify missing data. Any data queries will be discussed and
resolved directly with the responsible collaborating principal investigator.
Harmonization

To harmonize variables, we will collect information from
all studies and follow a conversion procedure consisting
of four steps: (1) importation of data into the data warehouse; (2) preparation for transformation of original
studies, including variable checking; (3) transformation
of the data labels of the original studies into the
POLARIS coding scheme and integration into the data
warehouse; and (4) export of specific variables into a
SPSS data file for the proposed statistical analyses.

Figure 2 Data harmonization process.
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POLARIS data management processes from the original
data sets from collaborating principal investigators to
the formation of the POLARIS database is described in
more detail in Figure 2.
Data confidentiality

Data made available for the POLARIS database will
remain the property of the investigators supplying the
data. Any data supplied will be held securely at the EMGO
Institute for Health and Care Research and will be treated
as confidential. All data included in the POLARIS project
will be anonymized by the principal investigators prior
to data transfer to the POLARIS center (if this has not
already been done). Only RCTs that had ethical committee
approval will be included in the POLARIS database.
Statistical analysis

To conduct the statistical analyses, we will pool individual patient data from RCTs contained in the POLARIS
database. We will conduct one-stage IPD meta-analyses
to evaluate the effect of physical activity and psychosocial interventions on HRQoL compared with wait-list,
usual care or attention control group. Clustering effects
from study to study will be taken into account by using
multilevel regression analyses with a two-level hierarchical structure: the patients within each trial as level 1
and the trial as level 2.
Moderators

To test for moderating effects, we will use moderated
multiple regression analyses (MMR) [33]. MMR is an extension of a multiple regression equation that includes
an interaction term providing information regarding a
potential moderating effect. The selection of moderators
will be based on a specific rationale (that is, a theory or
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evidence-based model) of why the intervention may be
more effective for some subgroups than for others. We
will examine interactions between the intervention and
potential categorical moderators (that is, demographic,
clinical and personal factors plus treatment such as
age, marital status, disease stage, type of treatment (for
example, chemotherapy) and baseline functioning). The
regression coefficient of the interaction term provides
information on whether the effect of the intervention on
the outcome differs across different moderator categories.
Before conducting MMR, we will check the homogeneity
of (within-group) error variance, that is, whether the error
variance for one moderator group is equal to the error
variance in the other moderator group(s) [33]. We will
do this by examining whether the residual variance is
constant across the moderator categories.
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into a clinical decision rule that may assist patients and
clinicians in making the most objective, evidence-based
and well-considered choice for optimal physical activity
or psychosocial interventions to improve HRQoL. This
model may guide treatment choice and may predict which
patient will benefit most from a specific treatment.
The performance of the prediction models will be evaluated using the Hosmer-Lemeshow goodness-of-fit test,
and the discriminative ability of the regression model
using the area under the receiver operating characteristics
(ROC) curve and its 95% confidence interval. Internal
validation of the model will be determined by a bootstrapping procedure with 200 replications. In each replication,
a random sample from the original dataset is drawn with
replacement. We will multiply the regression coefficients
by the shrinkage factor derived from the bootstrapping
procedures to quantify the amount of optimism and to correct for over-fitting if necessary.

Predictors

For each type of intervention, we will build prediction
models identifying predictors of intervention success (that
is, improvement in HRQoL), using multivariable backward
logistic regression analyses on pooled data [34,35]. We
will explore the need to account for trial variability in
these models. The variables with the highest P values will
be removed one by one, based on the Wald test, until all
remaining variables have a significant pre-determined P
value. Potential predictors include demographic, clinical
and personal and treatment characteristics at baseline.
Relevant moderators identified will also be taken into
account when building the prediction models. In addition,
we will build a clinical prediction model to select the most
successful intervention to improve HRQoL for (subgroups
of) patients. The predictors included in the model will
be checked for interactions with treatment by introducing interaction terms into the model, and evaluating
their contribution to the model. We will calculate the
probabilities of success for the different categories of
the predictors interacting with treatment [36]. Finally,
we will try to translate the clinical prediction model

Figure 3 Mediation analysis.

Mediators

Potential mediators of the intervention effect on HRQoL
will be explored according to the product‐of‐coefficients
test described by MacKinnon (Figure 3) [37]. The selection of mediators will be based on the theoretical framework of the included studies. First, we will estimate the
total intervention effect on the outcome (path c). Second,
we will estimate the intervention effect of the hypothesized mediator (path a). Third, we will estimate the association between the mediator and outcome, adjusted for
the intervention effect (path b). The final regression
model provides estimates for the b‐value and for the
direct association (c’‐path). The product of coefficients
(a × b) provides an estimate of the relative strength of
the mediation effect. The proportion mediated will be
estimated by dividing the mediation effect (a × b) by
the total direct effect (c = c’ + a × b). Subsequently, a
bootstrapping method (with n = 5,000 bootstrap
resamples) will be used to calculate the bias corrected
confidence intervals around the mediated and direct
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effects using the SPSS macro suggested by Preacher and
Hayes [38]. In case of multiple mediators, path models
and structural equation models will be constructed [37].
Project management

A Steering Committee (that is, LMB, JK, IMVdL, JB) has
been established and is responsible for the coordination
of the POLARIS project, advised by an international
advisory board consisting of experts in this research
field (that is, NKA, KSC, PBJ, RUN). Project coordination
and statistical analyses will be conducted at the EMGO
Institute for Health and Care Research and the Department of Epidemiology and Biostatistics of VU University
Medical Center, Amsterdam. Collaborating investigators
are welcome to propose additional research projects, to
develop analysis protocols and to spend time at the coordinating center conducting data analysis. The steering
committee will check for potential overlap with other
proposals, and subsequently, all collaborators will be
contacted to ask permission for the use of their data for
the proposed analysis. Collaborators may decline participation on a study-by-study basis, and have the right
to withdraw their data for future analyses.
Publication policy

The results of the specific meta-analyses will be presented to and discussed with all collaborators during a
collaborators meeting. Subsequently, the results will be
published in scientific peer-reviewed journals. The primary
publications will be in the name of the writing committee
as well as the collaborative group. The writing committee
for these primary publications will consist of the research
staff working in the analysis center and those collaborators
who have expressed interest in that particular analysis.
All co-authors need to comply with the criteria of the
Vancouver Protocol for co-authorship. The POLARIS
consortium will be listed as a group author, and all participating studies and investigators contributing to this
project will be listed at the end of each publication.

Discussion
The POLARIS consortium will conduct the first IPD
meta-analyses based on individual patient data, with
the goal of more effectively targeting physical activity or
psychosocial programs to cancer survivors. Furthermore,
insight into the moderators explaining which physical
activity or psychosocial intervention can improve HRQoL
for whom and under what circumstances is an essential
step towards personalized care for cancer survivors. IPD
meta-analysis allows for testing of interactions to evaluate
whether patient and setting characteristics are statistically
significantly related to treatment effects. Further, it may
allow us to build a clinical decision rule supporting
evidence-based decision making about which intervention
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would be most effective for a given outcome and a given
patient group. This can be an essential step to improve
care and optimize the patient’s HRQoL in an efficient and
evidence-based way. It may also help to identify subgroups
of patients for which effective interventions are not yet
available and thus need to be developed and evaluated.
Despite the strong study design allowing sophisticated
statistical analyses, an IPD meta-analysis is at risk for
‘retrieval bias’ if not all investigators of relevant studies
are willing or able to participate. However, estimated
effect sizes may still be valid because it is unlikely that
non-participation is associated with effect size.
In summary, the POLARIS consortium will start to
carry out a series of IPD meta-analyses evaluating the
effectiveness of physical activity and psychosocial interventions on the HRQoL of cancer survivors in order to
identify relevant moderators of intervention effects, and
will try to build a clinical prediction rule that may support
evidence-based decision making about which interventions are most likely to be effective at the individual
patient level.
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